Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 7Terminated 4Unknown 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Sarcoma 1Breast 1

Conditions

Carcinoma, Renal Cell 27Neoplasms 9Neoplasm Metastasis 9Breast Neoplasms 9Kidney Neoplasms 6Prostatic Neoplasms 4Gastrointestinal Stromal Tumors 4Carcinoma, Hepatocellular 4Brain Neoplasms 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplasms by Histologic Type 3Melanoma 3Liver Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Acute 3Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Primary Myelofibrosis 2Neuroendocrine Tumors 2Neoplasms, Glandular and Epithelial 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Site 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Digestive System Neoplasms 2Clear-cell metastatic renal cell carcinoma 2

Interventions

Temozolomide 28Radiosurgery 19Radiotherapy 17Bevacizumab 12Magnetic Resonance Spectroscopy 9Radiation 6Erlotinib Hydrochloride 6Carboplatin 6Topotecan 5Nivolumab 5Mental Status and Dementia Tests 5Irinotecan 5Capecitabine 5pembrolizumab 4dabrafenib 4Trastuzumab 4Sunitinib 4Pemetrexed 4Ipilimumab 4Filgrastim 4Cyclophosphamide 4Aminolevulinic Acid 42,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4cabozantinib 3Vorinostat 3TPI-287 3Specimen Handling 3Radiotherapy, Intensity-Modulated 3Methylphenidate 3Lomustine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Brain Neoplasms × Sunitinib × Clear all
NCT03641326 2022-04-19

Sunitinib in Sarcomas of the Central Nervous System

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
5 enrolled 14 charts
CNSSarcoma

Brain Neoplasms, Gliosarcoma

NCT00923117 2015-09-30

Sunitinib to Treat Recurrent Brain Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
87 enrolled 11 charts
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT00910039 2014-09-29

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Case Comprehensive Cancer Center

Phase 2 Terminated
14 enrolled 12 charts
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT00570908 2014-09-18

Brain Mets - Capecitabine Plus Sunitinib and WBRT

Baylor Breast Care Center

Phase 2 Terminated
12 enrolled 7 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡